Cargando…

Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy

PURPOSE: To compare the performance of eight metabolic indices for the early assessment of tumour response in patients with metastatic colorectal cancer (mCRC) treated with chemotherapy. METHODS: Forty patients with advanced mCRC underwent two FDG PET/CT scans, at baseline and on day 14 after chemot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maisonobe, Jacques-Antoine, Garcia, Camilo A., Necib, Hatem, Vanderlinden, Bruno, Hendlisz, Alain, Flamen, Patrick, Buvat, Irène
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537000/ https://www.ncbi.nlm.nih.gov/pubmed/23151911 http://dx.doi.org/10.1007/s00259-012-2274-x

Ejemplares similares

Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancer
por: Buvat, Irène, et al.
Publicado: (2012)

(90)Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer
por: Levillain, Hugo, et al.
Publicado: (2018)

Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer
por: Woff, Erwin, et al.
Publicado: (2016)

NOXA as critical mediator for drug combinations in polychemotherapy
por: Ehrhardt, H, et al.
Publicado: (2012)

Acute pancreatitis associated with multibacillary polychemotherapy for leprosy
por: Maciel, Lucas Guimarães, et al.
Publicado: (2021)

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol
por: Hendlisz, Alain, et al.
Publicado: (2015)

Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies
por: Rachiglio, Anna Maria, et al.
Publicado: (2022)

Quantitative Evaluation of Therapeutic Response by FDG-PET–CT in Metastatic Breast Cancer
por: Goulon, Dorothée, et al.
Publicado: (2016)

Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications
por: Boggio, Elena, et al.
Publicado: (2023)

Excellent Biochemical Response to Polychemotherapy with Nab-Paclitaxel/Gemcitabine in an 82-Year-Old Female with Metastatic Breast Cancer
por: Völkl, Siegfried J.
Publicado: (2014)

The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of Lymphosarcoma
por: Sen'kova, Alexandra V., et al.
Publicado: (2012)

Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient’s outcome in advanced colorectal cancer: the CORIOLAN study
por: Deleporte, Amelie, et al.
Publicado: (2014)

Combined quality and dose-volume histograms for assessing the predictive value of (99m)Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer
por: Levillain, Hugo, et al.
Publicado: (2020)

The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer
por: Hendlisz, Alain, et al.
Publicado: (2015)

Correction to: Combined quality and dose-volume histograms for assessing the predictive value of (99m)Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer
por: Levillain, Hugo, et al.
Publicado: (2021)

Desmoid Tumor Treated with Polychemotherapy Followed by Imatinib: A Case Report and Review of the Literature
por: Knechtel, Gudrun, et al.
Publicado: (2010)

Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy
por: Kebir, Sied, et al.
Publicado: (2012)

Adverse effects of polychemotherapy for leprosy in 13 years of follow-up at a university hospital()()
por: Tortelly, Violeta Duarte, et al.
Publicado: (2021)

BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR‐T cell cytotoxicity
por: Poussard, Margaux, et al.
Publicado: (2020)

Prognostic value of a three-scale grading system based on combining molecular imaging with (68)Ga-DOTATATE and (18)F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias
por: Karfis, Ioannis, et al.
Publicado: (2020)

A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer.
por: Pronzato, P., et al.
Publicado: (1996)

Multidrug Resistance Phenotype in the RMS‐GR Human Rhabdomyosarcoma Cell Line Obtained after Polychemotherapy
por: Prados, Jose, et al.
Publicado: (1999)

Achievement of complete in vitro spermatogenesis in testicular tissues from prepubertal mice exposed to mono- or polychemotherapy
por: Delessard, Marion, et al.
Publicado: (2022)

18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer
por: Orlhac, Fanny, et al.
Publicado: (2015)

Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab
por: Muylle, Kristoff, et al.
Publicado: (2015)

Prognostic Value of the Pace of Tumor Progression as Assessed by Serial (18)F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial
por: Camera, Silvia, et al.
Publicado: (2020)

HDMTX-based polychemotherapy including intraventricular therapy in elderly patients with primary CNS lymphoma: a single center series
por: Seidel, Sabine, et al.
Publicado: (2020)

N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by (89)Zr-Trastuzumab and (18)F-FDG PET imaging
por: Wimana, Zéna, et al.
Publicado: (2017)

Revisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials
por: Bailly, Clément, et al.
Publicado: (2016)

Evaluation of hypoxia in an experimental rat tumour model by [(18)F]Fluoromisonidazole PET and immunohistochemistry
por: Dubois, L, et al.
Publicado: (2004)

Sequential tumor-directed and lobar radioembolization before major hepatectomy for hepatocellular carcinoma
por: Vouche, Michael, et al.
Publicado: (2017)

FOLFIRI as second-line treatment of metastatic biliary tract cancer patients
por: Caparica, Rafael, et al.
Publicado: (2019)

Dual [(68)Ga]DOTATATE and [(18)F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score
por: Chan, David L., et al.
Publicado: (2022)

Accuracy and precision assessment for activity quantification in individualized dosimetry of (177)Lu-DOTATATE therapy
por: Marin, Gwennaëlle, et al.
Publicado: (2017)

FAP-targeted PET imaging in gastrointestinal malignancies: a comprehensive review
por: Arçay Öztürk, Ayça, et al.
Publicado: (2023)

Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer
por: Vera, Pierre, et al.
Publicado: (2014)

Clinico‐metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases
por: Bohlok, Ali, et al.
Publicado: (2021)

The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases: A Pilot Study
por: El Asmar, Antoine, et al.
Publicado: (2023)

Influence of age on radiomic features in (18)F-FDG PET in normal breast tissue and in breast cancer tumors
por: Boughdad, Sarah, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uue9plmskkjd590s63rgt3q4f3